$12.27
The latest share price target for Summit Therapeutics Inc (SMMT) is $12, offered by 7 analysts offering 12-month price forecasts.
Summit Therapeutics Inc (SMMT) has a maximum of -0.02 downside potential, based on 7 analysts offering 12-month price forecasts.
Based on 7 analysts tracking and researching Summit Therapeutics Inc (SMMT), 85.71% have a buy recommendation. Remaining 14.29% have either sell or hold recommendations.
The latest share price of Summit Therapeutics Inc (SMMT) is $12.27 as of 07/09/2024.
6 of total 7 analysts offering stock ratings for Summit Therapeutics Inc SMMT have recommended buy rating.